RAG-18
Asset
Small activating RNA (saRNA) targeting and upregulating endogenous utrophin expression.
- Stage
- Phase 1
- Modality
- Oligonucleotide
- Target
- UTRN
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Duchenne muscular dystrophy
Phase 1, prnewswire.com, 3 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Evidence for its targets1
Every asset’s record: target, stage, trials and the evidence behind it.